Lisata Therapeutics Inc. (LSTA)
LSTA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.08
+2.86% on the day
Market cap
$11.7M
Nano cap
Revenue · 2025
$170K
-83.0% on 2024
Net income · 2025
-$17.0M
-10000.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | LSTA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000320017 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $170K |
| Net income | -$17.0M |
| Operating income | -$18.2M |
| Net margin | -10000.0% |
| Operating margin | -10711.2% |
| Revenue growth | -83.0% |
| Cash | $16.0M |
| Total assets | $17.7M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 68.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2024-08-21 |
| Latest annual report | 10-K/A | 2026-04-28 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-10-14 |
| Latest proxy | PRE 14A | 2026-10-07 |
Source: SEC EDGAR submissions feed, 1,003 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ASBP | Aspire-Lakewood Holdings Inc. | $8.18 | +5.14% | $11.5M |
| AEON | AEON Biopharma Inc. | $0.2297 | -6.47% | $11.5M |
| TPST | Tempest Therapeutics Inc. | $0.6813 | -8.27% | $11.3M |
| ACTU | Actuate Therapeutics Inc. | $0.4663 | -27.56% | $11.2M |
| ENSC | Ensysce Biosciences Inc. | $0.5725 | +2.99% | $11.1M |
| KPRX | Kiora Pharmaceuticals Inc. | $2.47 | -3.52% | $10.9M |
| PHIO | Phio Pharmaceuticals Corp. | $0.9345 | +1.36% | $10.9M |
| BLRX | BioLineRx Ltd. | $2.17 | 0.00% | $10.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier